treatments Archives - Being Patient

Aduhelm aducanumab Alzheimer's drug explainer donanemab lecanemab

FDA Speeds Up Process for Two More Experimental Alzheimer’s Drugs: Donanemab, Lecanemab

By Alexandra Marvar | June 24th, 2021

This week, on the heels of Aduhelm’s FDA approval, the agency granted breakthrough status to two more prospective new Alzheimer’s treatments, Eli Lilly &…

With the #MoreTime campaign, the Alzheimer’s Association has gone all in on aducanumab, the controversial new Alzheimer’s drug produced by Biogen and Eisai.

aducanumab biogen Eisai treatments

‘It’s Time for More Time’: Alzheimer’s Association Goes All In On Not-Yet-Approved Aducanumab

By Phil Gutis | May 6th, 2021

With the #MoreTime campaign, the Alzheimer’s Association has gone all in on aducanumab, the controversial new Alzheimer’s drug produced by Biogen and Eisai. With…

dementia tech treatments virtual reality

What Can VR Therapy Do for Dementia and Alzheimer’s?

By Marian Williams | September 2nd, 2020

Many people think of virtual and augmented reality as popular forms of entertainment — but these technologies are becoming more central to healthcare, now…

Latest for #treatments